WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001085766) NOVEL EOSINOPHIL CATIONIC PROTEINS USED IN THE TREATMENT OF ASTHMATIC AND ALLERGIC DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/085766    International Application No.:    PCT/IB2001/000927
Publication Date: 15.11.2001 International Filing Date: 08.05.2001
Chapter 2 Demand Filed:    16.11.2001    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01), C12Q 1/68 (2006.01)
Applicants: INNOVENTUS PROJECT AB [SE/SE]; Uppsala Science Park, S-751 83 Uppsala (SE) (AE, AG, AL, AM, AT, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NE, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW only).
HÖGBOM, Erik [SE/SE]; (SE) (For US Only).
BYSTRÖM, Jonas [SE/SE]; (SE) (For US Only).
JÖNSSON, Ulla-Britt [SE/SE]; (SE) (For US Only).
VENGE, Per [SE/SE]; (SE) (For US Only)
Inventors: HÖGBOM, Erik; (SE).
BYSTRÖM, Jonas; (SE).
JÖNSSON, Ulla-Britt; (SE).
VENGE, Per; (SE)
Agent: NACHSHEN, Neil, Jacob; D. Young & Co., 21 New Fetter Lane, London EC4A 1DA (GB)
Priority Data:
0001706-1 09.05.2000 SE
Title (EN) NOVEL EOSINOPHIL CATIONIC PROTEINS USED IN THE TREATMENT OF ASTHMATIC AND ALLERGIC DISORDERS
(FR) SEQUENCES
Abstract: front page image
(EN)The present invention relates to novel eosinophil cationic proteins characterised by the presence of a single nucleotide polymorphism. The presence of such polymorphism has been correlated to an advantageous phenotype being a reduced disposition to allergic and asthmatic disorders.
(FR)L'invention concerne des nouvelles protéines cationiques éosinophiles, caractérisées par la présence d'un polymorphisme d'un nucléotide. La présence d'un tel polymorphisme a été corrélée à un phénotype avantageux qui possède une disposition moindre aux troubles allergiques et asthmatiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)